Diagenode

>>>   Click for Diagenode’s approach to COVID-19

Auto MethylCap kit

Catalog Number
Format
Price
C02020011
(AF-Auto01-0048)
48 rxns
$535.00

The Auto MethylCap kit allows to specifically capture DNA fragments containing methylated CpGs. The assay is based on the affinity purification of methylated DNA using methyl-CpG-binding domain (MBD) of human MeCP2 protein. This procedure has been optimized to perform automated immunoprecipitation of chromatin using the IP-Star® Compact Automated System enabling highly reproducible results and allowing for high throughput.

  • Characteristics
    • Fast & sensitive capture of methylated DNA
    • High capture efficiency
    • Differential fractionation of methylated DNA by CpG density (3 eluted fractions)
    • Automation compatibility

      MBD-seq allows for detection of genomic regions with different CpG density

      MBD-sequencing results have been validated by bisulfite sequencing

      Figure 1. Using the MBD approach, two methylated regions were detected in different elution fractions according to their methylated CpG density (A). Low, Medium and High refer to the sequenced DNA from different elution fractions with increasing salt concentration. Methylated patterns of these two different methylated regions were validated by bisulfite conversion assay (B).

  •  Documents
    Auto MethylCap kit MANUAL
    The Auto MethylCap kit allows to specifically capture DNA fragments containing methylated CpGs....
    Download
    Datasheet MethylCap Protein DATASHEET
    The MethylCap protein has been extensively validated for specific isolation of DNA fragments cont...
    Download
    DNA Methylation Solutions BROCHURE
    Complete solution for DNA methylation studies! Whether you are experienced or new to th...
    Download
  •  Publications

    How to properly cite this product in your work

    Diagenode strongly recommends using this: Auto MethylCap kit (Diagenode Cat# C02020011). Click here to copy to clipboard.

    Using our products in your publication? Let us know!

    Gene promoter and exon DNA methylation changes in colon cancer development - mRNA expression and tumor mutation alterations.
    Molnár B, Galamb O, Péterfia B, Wichmann B, Csabai I, Bodor A, Kalmár A, Szigeti KA, Barták BK, Nagy ZB, Valcz G, Patai ÁV, Igaz P, Tulassay Z
    BACKGROUND: DNA mutations occur randomly and sporadically in growth-related genes, mostly on cytosines. Demethylation of cytosines may lead to genetic instability through spontaneous deamination. Aims were whole genome methylation and targeted mutation analysis of colorectal cancer (CRC)-related genes and mRNA expre...

    Aberrant DNA methylation of WNT pathway genes in the development and progression of CIMP-negative colorectal cancer.
    Galamb O et al.
    The WNT signaling pathway has an essential role in colorectal carcinogenesis and progression, which involves a cascade of genetic and epigenetic changes. We aimed to analyze DNA methylation affecting the WNT pathway genes in colorectal carcinogenesis in promoter and gene body regions using whole methylome analysis i...

  •  Related products

       Site map   |   Contact us   |   Conditions of sales   |   Conditions of purchase   |   Privacy policy   |   Diagenode Diagnostics